Mulmit

Arcus Biosciences, Inc.Arcus Biosciences, Inc.

RCUS NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3133,000,000-386,000,000-353,000,000-3.29
2024-12-3151,000,000-330,000,000-283,000,000-3.14
2023-12-3137,000,000-340,000,000-307,000,000-4.15
2022-12-3138,000,000-280,000,000-267,000,000-3.71
2021-12-31383,000,00054,000,00053,000,0000.71

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-21Azoy AlexanderChief Accounting Officer2,827
2026-08-21Azoy AlexanderChief Accounting Officer2,827
2026-08-21Azoy AlexanderChief Accounting Officer2,827
2026-07-10Jaen Juan C.President19,799
2026-07-10Jaen Juan C.President268
2026-07-09Jaen Juan C.President48,502
2026-06-24Jaen Juan C.President6,431
2026-06-23Jaen Juan C.President14,067
2026-06-23Jaen Juan C.President1,697
2026-06-22Jaen Juan C.President9,236
2026-06-11Tang Carolyn C.General Counsel34,090
2026-06-11Tang Carolyn C.General Counsel34,090

8-K events

FiledItems
2026-08-05Results of operations · Financial statements and exhibits
2026-06-12Submission of matters to a vote
2026-05-05Results of operations · Financial statements and exhibits
2026-04-20Other events
2026-03-23Officer or director change
2026-02-25Results of operations · Financial statements and exhibits
2025-12-18Entry into a material agreement · Creation of a direct financial obligation
2025-12-12Other events
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.